Serogroup B Protein Meningococcal Vaccines and the Formation of Immune Protection against Gonorrhea
Relevance. Gonorrhea is a widespread infection. More than 80 million cases of this disease occur annually. The problem is compounded by the growing resistance of gonococcus to antibiotics worldwide. The only way out in this situation may be the immunization of certain groups of the population agains...
Saved in:
| Main Authors: | N. N. Kostyukova, V. A. Bekhalo |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Numikom LLC
2024-07-01
|
| Series: | Эпидемиология и вакцинопрофилактика |
| Subjects: | |
| Online Access: | https://www.epidemvac.ru/jour/article/view/2021 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
World Experience in the Use Serogroup B Meningococcal Vaccines (literature review)
by: I. S. Koroleva, et al.
Published: (2022-01-01) -
Meningococcal Vaccines of New Generations – the First 20 Years of Use
by: N. N. Kostyukova, et al.
Published: (2021-09-01) -
The Level of Meningococcal Carriage and Genotyping of N. meningitidis Strains in the Group of Labor Migrants
by: M. A. Koroleva, et al.
Published: (2020-11-01) -
The Course of Generalized Meningococcal Infection Caused by Meningococcus Serogroup W135
by: M. V. Ivanova, et al.
Published: (2016-11-01) -
An overview of the meningococcal disease and impact of the quadrivalent meningococcal conjugate vaccine
by: Asmaa Alrobai, et al.
Published: (2021-12-01)